Overview
A program is one drug in one indication at one company, as the company publishes it in its pipeline. Each program carries a normalized phase, a modality, the molecular target and mechanism when disclosed, the clinical trials linked to it, and the page it was read from. Questions this dataset answers:- Which companies have an oral GLP-1 agonist in development for obesity?
- Which KRAS G12C inhibitors are in Phase 3, and in which indications?
- What else is being developed that looks like this program?
- What is Eli Lilly’s full Phase 3 pipeline?
Coverage
Counts are from September 2026. Get current counts, and program counts per
phase and modality, from
GET /v1/stats. Partial
fields are listed in Coverage and sources.
Key fields
Full schema: List and search pipeline programs.
Endpoints
Filters
All filters are optional, repeatable, and combine with AND. Repeating a filter matches any of its values.Search programs by mechanism and phase
q finds programs by meaning, not only by exact words. Add filters to narrow
the ranked results.
Example response (trimmed)
Filter and count
Withoutq, the endpoint lists programs matching the filters. Pass
include_total=true for the exact count. Repeat phase to match several
phases.
Example response (trimmed)
indication is an exact match on the published indication text. For broader
recall across phrasings (“Metabolic (Obesity)”, “Obesity / Metabolic
Disease”), use q instead.
Find similar programs
Given a program id, return the programs most similar to it, ranked by similarity. Useful for finding competitors and analogues.Example response (trimmed)
Get one program
GET /v1/programs/{program_id} returns the full record, including linked
trials and ontology terms.
Example response (trimmed): GET /v1/programs/1833